Scranton sits in Lackawanna County in northeastern Pennsylvania, a region where the opioid crisis has hit hard and where both state and county agencies have mounted a sustained response. One notable development shaping the local treatment environment is Lackawanna County’s active Opioid Settlement Fund Committee, which oversees $1.9 million in pharmaceutical settlement funds earmarked for treatment programs and community initiatives. As of 2025, the committee is awarding grants to local providers, with a stated priority for locally incorporated organizations over large national treatment chains.
All detox and substance use disorder treatment facilities operating in Scranton must be licensed by the Pennsylvania Department of Drug and Alcohol Programs (DDAP), the state’s primary regulatory authority under the Pennsylvania Drug and Alcohol Abuse Control Act. At the local level, the Lackawanna/Susquehanna Office of Drug and Alcohol Programs (ODAP) coordinates county-level services and serves as the Single County Authority (SCA) connecting residents to funded treatment options.
Lackawanna County, which historically has a high per capita rate of opioid prescribing, benefits from a denser-than-average network of public, nonprofit and hospital-based services relative to the region’s population. Options include Geisinger Community Medical Center, which operates an Outpatient Addiction Medicine clinic in Scranton offering medication-assisted treatment with buprenorphine and naltrexone, along with intensive case management.
For persons seeking inpatient or residential services, Geisinger Marworth, located approximately 25 miles from Scranton in Waverly, PA, provides residential detox and rehabilitation within the Geisinger health system. Confirming insurance coverage, level-of-care needs and bed availability before arriving at a facility can save you significant time.
